富祥股份(300497.SZ):子公司取得變更生產範圍後的《藥品生產許可證》
格隆匯11月21日丨富祥股份(300497.SZ)公佈,近日,公司下屬控股子公司富祥(大連)製藥有限公司取得遼寧省藥品監督管理局換髮的《藥品生產許可證》,此次主要涉及生產範圍的變更,新增生產範圍:小容量注射劑。
此次公司取得小容量注射劑《藥品生產許可證》後,仍然需要進行藥品註冊,取得相關注冊審批許可後才能上市銷售。此次《藥品生產許可證》生產範圍的變更,有利於豐富公司的產品結構,將對公司增加註射劑品種產生長遠的積極作用,更好的滿足市場需求。短期內不會對公司的業績產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.